Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Neuropsychiatr Dis Treat. 2014 Jul 29;10:1415-22. doi: 10.2147/NDT.S66121. eCollection 2014.
To examine the relationship between level of insight and various subjective experiences for patients with schizophrenia.
Seventy-four patients with schizophrenia who were discharged from our hospital were evaluated. The level of insight into their illness and various subjective experiences were evaluated at discharge. We used the Scale to Assess Unawareness of Mental Disorder (SUMD) for evaluation of insight. In addition, five different rating scales were used to evaluate subjective experiences: Subjective Experience of Deficits in Schizophrenia (SEDS), Subjective Well-being under Neuroleptic drug treatment Short form (SWNS), Schizophrenia Quality of Life Scale (SQLS), Beck Depression Inventory (BDI), and the Drug Attitude Inventory (DAI)-30.
The SWNS and the scores for awareness of mental disorder and awareness of the social consequences of mental disorder on SUMD showed a weak positive correlation. The DAI-30 showed a significant negative correlation with most general items on SUMD and a negative correlation between the subscale scores for the awareness and attribution of past symptoms. SEDS, SWNS, SQLS, and the BDI significantly correlated with the subscale scores for awareness of current symptoms on SUMD, and weakly correlated with the subscale scores for attribution of current negative symptoms.
Awareness of subjective distress was related to awareness of having a mental disorder. Feeling subjective distress was related to awareness of current symptoms, as well as to the ability to attribute current negative symptoms to a mental disorder. Positive attitudes toward medication correlated with better general insight into the illness.
探讨精神分裂症患者的自知力水平与其各种主观体验之间的关系。
对我院出院的 74 例精神分裂症患者进行评估。在出院时评估其对疾病的自知力水平和各种主观体验。我们使用精神疾病认识量表(SUMD)评估自知力。此外,还使用了五种不同的评定量表评估主观体验:精神分裂症缺陷主观体验量表(SEDS)、抗精神病药物治疗下的主观幸福感简短量表(SWNS)、精神分裂症生活质量量表(SQLS)、贝克抑郁量表(BDI)和药物态度问卷(DAI)-30。
SWNS 和 SUMD 中对精神障碍的认识和对精神障碍社会后果的认识得分呈弱正相关。DAI-30 与 SUMD 中大多数一般项目呈显著负相关,与过去症状的认识和归因亚量表得分呈负相关。SEDS、SWNS、SQLS 和 BDI 与 SUMD 中对当前症状的认识亚量表得分显著相关,与当前阴性症状归因的亚量表得分呈弱相关。
对主观不适的认识与对精神障碍的认识有关。感到主观不适与对当前症状的认识有关,也与将当前阴性症状归因于精神障碍的能力有关。对药物的积极态度与对疾病的一般认识较好有关。